Results
1 -
10 of
16Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout, Clinical and Experimental Nephrology Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials, BMC Cardiovascular Disorders Effects of topiroxostat in hyperuricemic patients with chronic kidney disease, Clinical and Experimental Nephrology Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study, Clinical Rheumatology Effect of switching xanthine oxidoreductase inhibitor from febuxostat to topiroxostat on urinary protein excretion, Clinical and Experimental Nephrology A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients, Clinical and Experimental Nephrology